Location History:
- Maharashtra, IN (2014)
- Mumbai, IN (2011 - 2015)
Company Filing History:
Years Active: 2011-2015
Title: Innovator Divya Lal Saksena: Pioneering Advances in Pharmaceutical Patents
Introduction
Divya Lal Saksena is a prominent inventor based in Mumbai, India, known for her significant contributions to the field of pharmaceuticals. With an impressive portfolio of six patents, she has developed innovative solutions that enhance the preparation and analysis of therapeutic compounds. Her work is instrumental in advancing the science of drug formulation and development.
Latest Patents
Among her latest patents is "Copolymer-1, process for preparation and analytical methods thereof." This invention focuses on analytical methodologies for determining the molecular weight of polypeptides, specifically Glatiramer acetate. The patent outlines an improved process for the preparation of polypeptides or their pharmaceutically acceptable salts, with particular emphasis on Glatiramer acetate, also known as Copolymer-1. Furthermore, it details the characterization of Glatiramer acetate through peptide mapping.
Another key patent is the "Process for the synthesis of 37-mer peptide pramlintide," which presents a high-yield synthesis method for pramlintide, a 37-mer peptide. This innovative synthesis not only ensures a relatively pure form of the peptide but also offers further purification possibilities through preparative HPLC.
Career Highlights
Divya has made a mark in the industry through her extensive research and development efforts. At USV Private Limited, she collaborates with a talented team that includes notable coworkers like Nikhil Umesh Mohe and Chandrakesan Muralidharan. Her dedication to pushing the boundaries of pharmaceutical innovation has established her as a leading figure in her field.
Collaborations
Working alongside accomplished professionals, Divya fosters a collaborative environment that encourages the sharing of ideas and expertise. The synergy with her coworkers allows for a robust approach to problem-solving and innovation, ensuring that they stay at the forefront of pharmaceutical advancements.
Conclusion
Divya Lal Saksena continues to be a trailblazer in the realm of drug development and analytical methods. Her inventive spirit and commitment to enhancing pharmaceutical practices not only contribute to the scientific community but also pave the way for future innovations in healthcare. Through her patents, she demonstrates the vital role of inventors in shaping the landscape of medicine and therapy.